An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist - Test2 - elhamkhani - TriplyDB

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

http://www.wikidata.org/entity/Q24606097

about

IL-1 and T Helper Immune Responses Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency Autoinflammatory pustular neutrophilic diseases Interleukin-1 in the pathogenesis and treatment of inflammatory diseases Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions Canakinumab Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2 Regulatory Role of IL-1R8 in Immunity and Disease The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review Interleukin-1 Family Cytokines in Liver Diseases Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies Autoimmune valvular carditis Lighting the fires within: the cell biology of autoinflammatory diseases Autoinflammatory bone diseases Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence Advances in the genetically complex autoinflammatory diseases Interleukin-22 in kidney injury and regeneration.Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk Obesity, inflammation, and lung injury (OILI): the good.A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.Working the endless puzzle of hereditary autoinflammatory disorders.An autoinflammatory disease due to homozygous deletion of the IL1RN locus.The expanding spectrum of rare monogenic autoinflammatory diseases.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis.In vivo immune signatures of healthy human pregnancy: Inherently inflammatory or anti-inflammatory?Nonbacterial osteitis in children: data of a German Incidence Surveillance Study.Why not treat human cancer with interleukin-1 blockade?The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)-a systematic review.Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice.Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi infections.Deregulation of the IL-1β axis in chronic recurrent multifocal osteomyelitis.

P2860

Q21131213-B3CED8C2-3D6E-4D75-BBEC-043BF5BA44BA Q24301912-CA0A7673-AB89-4879-AA30-45CB1151BD76 Q24603182-D6E3F1BA-967E-4BFB-BF26-FAEBE420F022 Q24606766-6034DCE8-CA29-4D9C-834C-C76B991CE347 Q24629755-4DA49C14-CF6B-495C-92D6-745D2C313E19 Q24642193-75D91370-E3E2-49F4-B142-E6D40A33A262 Q26744783-B0FF23FF-A544-457B-8282-1F36BF8C6B14 Q26752524-3F654DB7-FBDE-4F67-8450-29D7293C1EF9 Q26768281-428B802B-82A8-4F4F-973F-95702F7B188F Q26778553-1F03FE3B-04B7-4BDA-BBE0-CCB888558013 Q26779192-613CBB9F-D233-4B20-92C9-124E7445BB6C Q26799747-1D1687EA-CF21-40A8-BFBB-EC98B34BFFE1 Q26825666-ABD57672-7C79-4D01-BA50-390B14E1830E Q26827163-6EB8FB5D-7FB2-45D1-91AC-8D6BA24F33E1 Q26829850-089D2B89-38A9-429A-8BF3-24F21E3A24C5 Q27002805-EB2580AD-FAE6-4EEB-93DE-4F6E4B21AEE0 Q27011650-48383702-3362-4DFC-A17E-3EF5BDEC3C62 Q27025795-880B1651-0B72-4B5E-B1BE-6B2BE5C189D1 Q27687335-DF7DAE28-B88B-4110-AC68-704D56222554 Q28066401-42038BE9-9A6D-4E2A-BA07-1A8D23AF635D Q28070297-92003FA7-9F7F-4041-B890-28574952830A Q28540595-F9C56052-09A9-43B1-99EE-3D656DEC40A6 Q28587108-ADC6B3E0-6F16-4481-87AC-0AD9A4EFF5D3 Q30363313-AC0ABED8-F97B-454A-8FCB-AF6E043EDE39 Q30397342-A5F3B9BE-EC15-4E0C-9113-69E103B9968E Q30469652-5F07AB7B-0E49-4CDC-9E9D-D3811B051BE9 Q33357128-1A54022B-ACAA-4149-9209-2F5B85ACB845 Q33577198-AFC17104-BBE7-49EA-8649-416A2DEE3C32 Q33592763-CF89A8F4-CCAD-43D4-B058-B1759DEE81A9 Q33710807-88E51E98-D4C9-4419-80F4-CE65A781EA40 Q33724394-3AC275D4-9913-49EB-B7CE-23297E203A24 Q33798590-0C7C34EA-DF05-4339-93D5-8404950458F2 Q33808382-235A81FC-F501-4A9E-9A31-2DCEAA308457 Q33821861-C07BF417-7FCA-4D33-88E6-3732F21A58BD Q33829999-C6477FFF-DF06-45BA-BA1C-99B821A14DCF Q33833871-64AAE1A2-0F13-4E07-93BA-6244796885F5 Q33881640-9E30B531-E35E-41C1-BB8E-E654D62AC233 Q33936499-38C8CEED-D048-4172-B845-825A16EE7E8B Q33936657-DC051E1F-1A60-484A-9365-86324027AB91 Q33945041-84DE8F73-B75D-4092-A031-7E665998B9A4

P2860

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

http://www.wikidata.org/entity/Q24606097

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@ast

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@en

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@nl

type

label

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@ast

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@en

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@nl

prefLabel

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@ast

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@en

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@nl

P1433

Q24606097-94F3AAEC-4DB3-4289-BD54-6B0078DDE593

P1476

Q24606097-80933D19-7882-4E48-99A1-C17670AB8F4F

P2093

Q24606097-014A9C75-52F3-4BBC-B293-894F1D1143DF

Q24606097-0BA28BF9-16BB-4F0A-8893-67B843F75E50

Q24606097-1713E832-8F35-4920-9E71-D9AF7ED7D847

Q24606097-24046518-8C92-4860-A8A6-5E8D703BE55D

Q24606097-240FA898-0AC4-41F0-ACA0-2E377D3ED6AA

Q24606097-26768A47-CA7F-489E-9740-46609B9C4D73

Q24606097-3E11EC3B-7757-4AFF-ACF5-B4949A72CAA2

Q24606097-3F3F0202-49CE-4302-B3CF-7F7768981A2D

Q24606097-510AC26F-63FD-4D9C-BDCE-DDC683099D8B

Q24606097-547ADF53-3C39-4B56-81DB-F351E77DF23A

P2860

Q24606097-03AB661D-72C0-400B-9326-2927A6CA9B8B

Q24606097-05D4098C-8C87-4691-B488-AFB23F5607CF

Q24606097-0DBE376C-E0C0-4E3C-BA80-B96BD377D698

Q24606097-37D9B857-1A54-494A-8333-EE6BCCA1A608

Q24606097-690011E1-574D-4188-AA75-7970A2F6CBA5

Q24606097-708676D7-763D-4BE2-AA77-C54B7A2D5A86

Q24606097-7FDCAA9F-9CC8-470C-836B-99D265ACC8C1

Q24606097-882C0685-D87D-415B-82EC-BFF1C76D82AA

Q24606097-8B9E45B0-E293-4875-B272-52077B9681E9

Q24606097-9050E61C-3BCD-4032-A094-8C235D0A0223

P304

Q24606097-A906CC8C-9363-4727-BE16-A6BE9FC72FFC

P31

Q24606097-9BAD26C7-6C7B-4B24-A349-1D5E410B6CCA

P3181

Q24606097-FC732ED4-8656-47FA-8FFC-9669D36C7287

P356

Q24606097-00E9D479-C552-4B48-825F-79F125324377

P407

Q24606097-9AFA4C08-BB72-4F9B-BB1E-E576E2972911

P433

Q24606097-085B9566-EB39-47C4-ACE1-CAE52312C915

P478

Q24606097-8450D7A0-467E-4055-A5DE-CA6CABD00038

P50

Q24606097-5D59A3B1-51EB-4E5A-82FC-F4C50DB34B60

Q24606097-6185E1BB-3431-468B-85DD-8A7E88E598E9

Q24606097-670F5257-2933-4AEC-ADE5-E01A255B5B77

Q24606097-7F216CDC-C409-4733-AAC7-F017E77AA7DD

Q24606097-81C102B8-899C-448A-9DEB-63431404AFE6

Q24606097-83633D6B-2D9E-49B9-9AB0-88C1D320D7DB

Q24606097-ABE13745-6BAB-4B81-A871-467F58FC4B65

Q24606097-B3AA008E-D2D8-4350-94E8-F4264F753843

Q24606097-B437C8B6-DA2B-47D3-AB11-600FE5C3034B

Q24606097-BBDE48C6-272C-4C7D-9B6B-8B2052210D4C

P577

Q24606097-1086D56A-F533-4241-8D9D-3194BF39D610

P698

Q24606097-C1C415E7-E096-4BAE-8C51-E14DEE4A0572

P921

Q24606097-c626c398-e523-4c0e-90ae-daa3f7296062

P932

Q24606097-37506158-B11C-4E56-90AB-7E93EE054FAE

P3181

P356

P1433

The New England Journal of Medicine

P1476

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

@en

P2093

A Elisabeth Hak

http://www.w3.org/2001/XMLSchema#string

Annet van Royen-Kerkhoff

http://www.w3.org/2001/XMLSchema#string

Barbara Yang

http://www.w3.org/2001/XMLSchema#string

Benjamin D Korman

http://www.w3.org/2001/XMLSchema#string

Daniel C Douek

http://www.w3.org/2001/XMLSchema#string

Daniel L Kastner

http://www.w3.org/2001/XMLSchema#string

Dawn Chapelle

http://www.w3.org/2001/XMLSchema#string

Deborah L Stone

http://www.w3.org/2001/XMLSchema#string

Edward W Cowen

http://www.w3.org/2001/XMLSchema#string

Elena Pope

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder

Cloning and characterization of IL-1HY2, a novel interleukin-1 family member

Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

Biologic basis for interleukin-1 in disease

An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

P304

2426-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

887216

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0807865

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Matthew G. Booty

Elaine F. Remmers

Netanya G. Sandler

Hatem El-shanti

Chyi-Chia R Lee

P577

2009-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19494218

http://www.w3.org/2001/XMLSchema#string

P921

P932

2876877

http://www.w3.org/2001/XMLSchema#string